Ligand Pharma (LGND) Licenses Captisol-Enabled Clopidogrel from The Medicines Co. (MDCO)
Go back to Ligand Pharma (LGND) Licenses Captisol-Enabled Clopidogrel from The Medicines Co. (MDCO)| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.43 +1.04 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.39 | 52 Week High | $139.79 | |||
| Open | $288.09 | 52 Week Low | $82.07 | |||
| Day High | $289.98 | P/E | 670.77 | |||
| Day Low | $285.87 | EPS | $0.43 | |||
| Volume | 57,977 | |||||
| Medicines Co (NASDAQ: MDCO) | Delayed: 84.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.90 | 52 Week High | $43.00 | |||
| Open | $3.15 | 52 Week Low | $27.50 | |||
| Day High | $84.90 | P/E | 339.60 | |||
| Day Low | $84.90 | EPS | $0.25 | |||
| Volume | 413,822 | |||||
